SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-010206
Filing Date
2019-08-07
Accepted
2019-08-06 20:43:45
Documents
65
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a20190630-10q.htm   iXBRL 10-Q 1533312
2 EXHIBIT 10.1 bold-20190630xex101.htm EX-10.1 51775
3 EXHIBIT 10.2 bold-20190630xex102.htm EX-10.2 63957
4 EXHIBIT 31.1 bold-20190630xex311.htm EX-31.1 12197
5 EXHIBIT 31.2 bold-20190630xex312.htm EX-31.2 12356
6 EXHIBIT 32.1 bold-20190630xex321.htm EX-32.1 5837
7 EXHIBIT 32.2 bold-20190630xex322.htm EX-32.2 5766
  Complete submission text file 0001628280-19-010206.txt   6107928

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bold-20190630.xsd EX-101.SCH 32850
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bold-20190630_cal.xml EX-101.CAL 67945
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bold-20190630_def.xml EX-101.DEF 136981
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bold-20190630_lab.xml EX-101.LAB 503926
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bold-20190630_pre.xml EX-101.PRE 288171
13 EXTRACTED XBRL INSTANCE DOCUMENT a20190630-10q_htm.xml XML 1015100
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Filer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37833 | Film No.: 191003626
SIC: 2836 Biological Products, (No Diagnostic Substances)